Warren, Carmen M <br/><br/>
A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes.  [electronic resource] 

 -  Science signaling  Jan 2014 
 - ra1 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1937-9145 
<br/><br/><label>Standard No.: </label>10.1126/scisignal.2004235  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcysteine--pharmacology<br/>Animals<br/>Blood Vessels--metabolism<br/>Cell Movement--drug effects<br/>Cells, Cultured<br/>Diabetes Mellitus, Experimental--genetics<br/>Dose-Response Relationship, Drug<br/>Endothelium, Vascular--drug effects<br/>Free Radical Scavengers--pharmacology<br/>Glucose--pharmacology<br/>Golgi Apparatus--drug effects<br/>Human Umbilical Vein Endothelial Cells--drug effects<br/>Humans<br/>Immunoblotting<br/>Ligands<br/>Mice<br/>Mice, Knockout<br/>Mice, Obese<br/>Mice, Transgenic<br/>Phosphorylation--drug effects<br/>Reactive Oxygen Species--metabolism<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Signal Transduction--drug effects<br/>Vascular Endothelial Growth Factor A--genetics<br/>Vascular Endothelial Growth Factor Receptor-2--genetics